Trial intelligence / Profile preview

FMT Capsules in Severe IBS (ICEBOAT)

NCT06433180Phase 3Not yet recruiting

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jul 2025
Primary completion
Jul 2028
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 3 trial of Fecal Microbiota Transplantation Capsule in irritable bowel syndrome (IBS), sponsored by Assistance publique - Hôpitaux de Paris. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

Fecal Microbiota Transplantation Capsule
03

Conditions

irritable bowel syndrome (IBS)

Beyond the preview

Go deeper on NCT06433180.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06433180.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call